AlloSource received a patent for its new cartilage repair allograft, ProChondrix Cartilage Restoration Matrix.
Analysts expect Amedica to report revenue of $4.78 million for the fourth quarter.
Centinel Spine received FDA clearance for its ALTOS device.
Zacks analysts upgraded CONMED shares from a “hold” rating to a “buy” rating.
Technavio’s new report shows that DePuy Synthes, Medtronic, NuVasive and Stryker are the top four leading vendors in the U.S. lateral lumbar interbody fusion market.
EOS imaging formed a new partnership with Montreal-based Spinologics.
Integra LifeSciences shares received a crowd sourced rating of four on a scale of one to five, on which five is a considered a “strong buy.”
Johnson & Johnson plans to cut about 3,000 jobs in its medical-devices division.
Medtech, a Montpellier, France-based surgical robotic company, named Teresa Prego its marketing director.
NuVasive expects 2015 revenue to reach $811 million, a 6 percent increase from 2014.
OrthAlign successfully completed its limited release phase of OrthAlign Plus for total hip arthroplasty use in the direct anterior hip approach.
OsteoVantage was awarded a Small Business Innovation and Research Phase I grant by the National Science Foundation.
San Jose, Calif.-based SI-BONE expanded its presence in Europe with the creation of SI-BONE UK, to be based in Knaresborough, North Yorkshire, United Kingdom.
MidCap Business Credit completed a $6 million asset-based line of credit to Boston-based SpineFrontier.
Needham has downgraded Stryker stock to a “hold” rating.
VGI Medical received FDA 510(k) clearance to market its VerteLP Lateral Lumber Cage System.
More articles on devices:
Analysts weigh in on Amedica’s expected Q4 earnings — 5 highlights
NuVasive expects revenue to reach $811M in 2015 — 4 quick notes
Needham downgrades Stryker to “hold” rating: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
